Hims & Hers Completes Eucalyptus Acquisition, Expands Global Health Platform
HIMS has more than doubled off its 52-week low of $13.74.
Summary
Hims & Hers Health, Inc. completed its acquisition of Eucalyptus, significantly expanding its international presence and reinforcing its position as a global consumer health platform, supported by an amendment to its credit agreement.
Key Events · M&A and Partnerships · HIMS
-
Acquisition Completed
Hims & Hers Health, Inc. announced the completion of its acquisition of EUC Management Pty Ltd (d/b/a Eucalyptus), an Australian digital health platform.
-
Global Platform Expansion
This acquisition, combined with previous deals, establishes Hims & Hers as a leading consumer health platform across the US, UK, Australian, and Canadian markets, with a growing presence in Europe and Japan.
-
Reinforces Long-Term Targets
The company stated this global expansion reinforces its confidence in achieving long-term targets of $6.5 billion in revenue and $1.3 billion in Adjusted EBITDA by 2030.
-
Credit Agreement Amended
Hims & Hers amended its Revolving Credit and Guaranty Agreement to facilitate the Eucalyptus acquisition, including a grace period for covenant compliance and increased downstream investment capacity in non-loan party subsidiaries.
Analysis · HIMS · Industrial Applications And Services
Hims & Hers Health, Inc. has completed its acquisition of Eucalyptus, a strategic move to significantly expand its international footprint and customer base. This acquisition, following previous deals, positions the company as a leading global consumer health platform and is expected to contribute to its long-term revenue and Adjusted EBITDA targets. The company also amended its revolving credit agreement to facilitate the acquisition, including adjusting covenants and increasing investment capacity in non-loan party subsidiaries.
How filings like this one have moved
In the 30 days to Oct 2, 2026, 36.5% of the 1055 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HIMS was trading at $27.99 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $6.2B. The 52-week trading range was $13.74 to $70.43. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.